Showing all results Page 1 of 4

The Future of Point-of-Care (POC) Testing in Asia-Pacific (APAC)

August 24th, 2021

Point-of-care diagnostics is expected to be one of the fastest-growing major in-vitro diagnostics market segments in Asia-Pacific. Find our more in our latest report.

  • Clearstate Insights
  • Healthcare
  • Asia
  • IVD Gateway
  • Point-of-care diagnostics

The Future of Pathology: Four Growth Areas in Tissue Diagnostics (TDx)

June 28th, 2021

Various technologies and advancements in tissue diagnostics (TDx) will drive greater efficiency in pathology which is crucial for delivering improved cancer care and diagnosis amid the growing global cancer burden. Download our latest infographic to learn more

  • Clearstate Insights
  • Healthcare
  • Global
  • EIU Healthcare
  • IVD Gateway
  • Tissue Diagnostics (TDx)

Sign up for the Clearstate newsletter

June 21st, 2021

Sign up to the EIU Healthcare newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.

  • Campaign
  • Healthcare
  • Global
  • Healthcare

LATAM IVD market to grow 2.8 per cent annually between 2019 to 2024

April 28th, 2021

The Latin America (LATAM) in-vitro diagnostics (IVD) market is expected to recover in 2024 after government measures to mitigate the worsening socioeconomic crisis amidst the Covid-19 pandemic. Find out more in our LATAM IVD market update

  • Clearstate Insights
  • Healthcare
  • Americas
  • Healthcare
  • IVD Gateway

APAC IVD market to grow 4.4 per cent annually between 2019 to 2024

April 28th, 2021

The Asia-Pacific (APAC) in-vitro diagnostics (IVD) market will continue to see key trends in hospital and patient care, government policies which will drive up overall diagnosis needs, and fuel fast growth for certain market segments. Find out more in our APAC IVD market update

  • Clearstate Insights
  • Healthcare
  • Asia
  • Healthcare
  • IVD Gateway

[On-demand Webinar] Covid-19 Impact: Molecular Diagnostic (MDx) Market

January 12th, 2021

EIU Healthcare zooms in on two of the fastest-growing molecular testing areas: cancer and Covid-19 testing to uncover the market opportunities for IVD companies. Register to watch the webinar recording.

  • Clearstate Insights
  • Healthcare
  • Asia
  • Europe
  • Global
  • EIU Healthcare
  • IVD Gateway
  • Molecular Diagnostics (MDx)